Rodman, G. K., & DasGupta, S. (2022). Beyond Trans competency: imagining a Trans liberatory future. The Lancet, 399(10324), 514–515. https://doi.org/10.1016/s0140-6736(22)00198-2

Polizzotto, M. N., Nordwall, J., Babiker, A. G., Phillips, A., Vock, D. M., Eriobu, N., Kwaghe, V., Paredes, R., Mateu, L., Ramachandruni, S., Narang, R., Jain, M. K., Lazarte, S. M., Baker, J. V., Frosch, A. E. P., Poulakou, G., Syrigos, K. N., Arnoczy, G. S., McBride, N. A., … Lane, H. C. (2022). Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial. The Lancet, 399(10324), 530–540. https://doi.org/10.1016/s0140-6736(22)00101-5

Xu, B., Tu, S., Song, L., Jin, Z., Yu, B., Fu, G., Zhou, Y., Wang, J., Chen, Y., Pu, J., Chen, L., Qu, X., Yang, J., Liu, X., Guo, L., Shen, C., Zhang, Y., Zhang, Q., Pan, H., … Stone, G. W. (2021). Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trial. The Lancet, 398(10317), 2149–2159. https://doi.org/10.1016/s0140-6736(21)02248-0

Omer, S. B., Benjamin, R. M., Brewer, N. T., Buttenheim, A. M., Callaghan, T., Caplan, A., Carpiano, R. M., Clinton, C., DiResta, R., Elharake, J. A., Flowers, L. C., Galvani, A. P., Lakshmanan, R., Maldonado, Y. A., McFadden, S. M., Mello, M. M., Opel, D. J., Reiss, D. R., Salmon, D. A., … Hotez, P. J. (2021). Promoting COVID-19 vaccine acceptance: recommendations from the Lancet Commission on Vaccine Refusal, Acceptance, and Demand in the USA. The Lancet, 398(10317), 2186–2192. https://doi.org/10.1016/s0140-6736(21)02507-1

Karim, S. S. A., & Karim, Q. A. (2021). Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic. The Lancet, 398(10317), 2126–2128. https://doi.org/10.1016/s0140-6736(21)02758-6

Charon, R. (2021). Knowing, seeing, and telling in medicine. The Lancet, 398(10316), 2068–2070. https://doi.org/10.1016/s0140-6736(21)02656-8

Ruperto, N., Brunner, H. I., Synoverska, O., Ting, T. V., Mendoza, C. A., Spindler, A., Vyzhga, Y., Marzan, K., Grebenkina, L., Tirosh, I., Imundo, L., Jerath, R., Kingsbury, D. J., Sozeri, B., Vora, S. S., Prahalad, S., Zholobova, E., Butbul Aviel, Y., Chasnyk, V., … Weiss, J. (2021). Tofacitinib in juvenile idiopathic arthritis: a double-blind, placebo-controlled, withdrawal phase 3 randomised trial. The Lancet, 398(10315), 1984–1996. https://doi.org/10.1016/s0140-6736(21)01255-1

Ward, J. L., Azzopardi, P. S., Francis, K. L., Santelli, J. S., Skirbekk, V., Sawyer, S. M., Kassebaum, N. J., Mokdad, A. H., Hay, S. I., Abd-Allah, F., Abdoli, A., Abdollahi, M., Abedi, A., Abolhassani, H., Abreu, L. G., Abrigo, M. R. M., Abu-Gharbieh, E., Abushouk, A. I., Adebayo, O. M., … Viner, R. M. (2021). Global, regional, and national mortality among young people aged 10–24 years, 1950–2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet, 398(10311), 1593–1618. https://doi.org/10.1016/s0140-6736(21)01546-4

Schuetz, P., Seres, D., Lobo, D. N., Gomes, F., Kaegi-Braun, N., & Stanga, Z. (2021). Management of disease-related malnutrition for patients being treated in hospital. The Lancet, 398(10314), 1927–1938. https://doi.org/10.1016/s0140-6736(21)01451-3

Barbaro, R. P., MacLaren, G., Boonstra, P. S., Combes, A., Agerstrand, C., Annich, G., Diaz, R., Fan, E., Hryniewicz, K., Lorusso, R., Paden, M. L., Stead, C. M., Swol, J., Iwashyna, T. J., Slutsky, A. S., & Brodie, D. (2021). Extracorporeal membrane oxygenation for COVID-19: evolving outcomes from the international Extracorporeal Life Support Organization Registry. The Lancet, 398(10307), 1230–1238. https://doi.org/10.1016/s0140-6736(21)01960-7